News » MHRA alert » Alert: labetalol 200mg tablets
October 29th 2024
Tillomed Laboratories Limited is recalling one batch of labetalol 200mg tablets as a precautionary measure due to potential product mix-up.
A limited number of labetalol 200mg tablets cartons may also contain a blister strip of Vera-Til SR 240mg tablets (verapamil).
The affected batch is
| Batch Number | Expiry Date | Pack Size | First Distributed | |
| 240537 | 02/2027 | 56 (4x14) | 21/05/2024 |
Images showing the correct and incorrect blister strips can be found in the ‘Download document’ information.
Healthcare professionals are asked to quarantine all remaining stock and return it to your supplier using your supplier’s approved process
They should also contact all patients who have been dispensed the impacted batch and ask them to confirm if they have remaining stock within their possession. If batch traceability information is not available, all patients dispensed this product from May 2024 should be contacted. Patients should be advised to check for this batch number and return any packs that contain the incorrect blister strips to their dispenser.
Where patients pay for NHS prescriptions, a charge for the new prescription will apply; patients may contact the Defective Medicines Reporting Centre if further information is required.
